Zogenix Inc. (ZGNX) Leaped To A New High On Phase 3 Study Results

Zogenix Inc. (ZGNX) announced Thursday morning that its second Phase 3 study of ZX008 met the primary endpoint and all key secondary endpoints.

from RTT - Before the Bell https://ift.tt/2NdKs90
via IFTTT